With nearly 100 scientists focused solely on malaria, SBRI is home to one of the largest malaria research programs in the United States. Study of this complex parasite has led SBRI researchers to fundamental discoveries of the genetic framework and molecular biology of Plasmodium falciparum, the malaria parasite responsible for the majority of deaths due to the disease.

As part of a broad global initiative to fight malaria, SBRI developed its Malaria Program in 2000, with an initial grant from the Bill & Melinda Gates Foundation. Using a three-pronged approach, SBRI's Malaria Program is focused on vaccine discovery for pregnancy malaria, severe malaria in children and liver-stage malaria.

In 2008, SBRI announced that it will be home to the Malaria Clinical Trials Center (MCTC), an innovative center for the integration of basic science and clinical research uniquely focused on bringing new malaria solutions to the world.   (You can find the press release about SBRI's partnership with PATH Malaria Vaccine Initiative here.) 

For more information about malaria in general, please visit the Centers for Disease Control  or the World Health Organization.

HOME | CONTACT US | SITEMAP | DONATE | POLICY

©2008 Seattle Biomedical Research Institute. All rights reserved.

SBRI is a 501(c)3 not-for-profit organization. info@sbri.org